Taken together, these in vitro experiment results that we have presented so far indicated that GPC2 might be a potential therapeutic target in prostate cancer, further exploration should be conducted in vivo to confirm the anti-tumor efficiency of GPC2-based target therapy. This evidence concerns the gene GPC2 and neoplasm.